Search Results - "MANOLIS, Antonis S"

Refine Results
  1. 1

    Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue by Manolis, Antonis S, Manolis, Theodora A, Manolis, Antonis A

    “…The increased metabolic activity of the heart as a pump involves a high demand of mitochondrial adenosine triphosphate (ATP) production for its mechanical and…”
    Get full text
    Journal Article
  2. 2

    Neurohumoral Activation in Heart Failure by Manolis, Antonis A, Manolis, Theodora A, Manolis, Antonis S

    “…In patients with heart failure (HF), the neuroendocrine systems of the sympathetic nervous system (SNS), the renin-angiotensin-aldosterone system (RAAS) and…”
    Get full text
    Journal Article
  3. 3

    The role of the autonomic nervous system in cardiac arrhythmias: The neuro-cardiac axis, more foe than friend? by Manolis, Antonis A., Manolis, Theodora A., Apostolopoulos, Evdoxia J., Apostolaki, Naomi E., Melita, Helen, Manolis, Antonis S.

    Published in Trends in cardiovascular medicine (01-07-2021)
    “…The autonomic nervous system (ANS) with its two limbs, the sympathetic (SNS) and parasympathetic nervous system (PSNS), plays a critical role in the modulation…”
    Get full text
    Journal Article
  4. 4

    Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call? by Manolis, Antonis A., Manolis, Theodora A., Melita, Helen, Manolis, Antonis S.

    Published in Trends in cardiovascular medicine (01-02-2020)
    “…Subclinical thyroid dysfunction (STD), presenting as subclinical hypothyroidism (SHypo) or subclinical hyperthyroidism (SHyper), defined as abnormal serum…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Lipoprotein(a) and Cardiovascular Disease: A Missing Link for Premature Atherosclerotic Heart Disease and/or Residual Risk by Melita, Helen, Manolis, Antonis A., Manolis, Theodora A., Manolis, Antonis S.

    Published in Journal of cardiovascular pharmacology (01-01-2022)
    “…Lipoprotein(a) or lipoprotein "little a" [Lp(a)] is an under-recognized causal risk factor for cardiovascular (CV) disease (CVD), including coronary…”
    Get full text
    Journal Article
  7. 7

    Is Atherothromboaspiration a Possible Solution for the Prevention of No-Reflow Phenomenon in Acute Coronary Syndromes? Single Centre Experience and Review of the Literature by Manolis, Antonis S

    Published in Current vascular pharmacology (01-01-2019)
    “…Intracoronary thrombus in acute Myocardial Infarction (MI) confers higher rates of no-reflow with attendant adverse consequences. Earlier…”
    Get more information
    Journal Article
  8. 8

    Neuropsychiatric disorders in patients with heart failure: not to be ignored by Manolis, Theodora A., Manolis, Antonis A., Melita, Helen, Manolis, Antonis S.

    Published in Heart failure reviews (01-07-2023)
    “…Among various neuropsychiatric disorders, depression and anxiety are commonly encountered in patients with heart failure (HF), reported in ≥ 50% of patients…”
    Get full text
    Journal Article
  9. 9

    Diet and Sudden Death: How to Reduce the Risk by Manolis, Antonis S, Manolis, Theodora A, Manolis, Antonis A, Melita, Helen

    Published in Current vascular pharmacology (01-01-2022)
    “…In addition to the association of dietary patterns, specific foods and nutrients with several diseases, including cardiovascular disease and mortality, there…”
    Get more information
    Journal Article
  10. 10

    Patients with Polyvascular Disease: A Very High-risk Group by Manolis, Antonis A, Manolis, Theodora A, Manolis, Antonis S

    Published in Current vascular pharmacology (01-01-2022)
    “…Polyvascular disease (PolyvascDis) with atherosclerosis occurring in >2 vascular beds (coronary, carotid, aortic, visceral and/or peripheral arteries) is…”
    Get more information
    Journal Article
  11. 11
  12. 12

    “Real life” longevity of implantable cardioverter‐defibrillator devices by Manolis, Antonis S., Maounis, Themistoklis, Koulouris, Spyridon, Vassilikos, Vassilios

    Published in Clinical cardiology (Mahwah, N.J.) (01-09-2017)
    “…Background Manufacturers of implantable cardioverter‐defibrillators (ICDs) promise a 5‐ to 9‐year projected longevity; however, real‐life data indicate…”
    Get full text
    Journal Article
  13. 13

    Exercise and Arrhythmias: A Double-Edged Sword by MANOLIS, ANTONIS S., MANOLIS, ANTONIS A.

    Published in Pacing and clinical electrophysiology (01-07-2016)
    “…Ample evidence indicates that moderate regular exercise is beneficial for both normal individuals and patients with cardiovascular (CV) disease. However,…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Cardiovascular Disease in Antiphospholipid Syndrome by Polytarchou, Kali, Varvarousis, Dimitrios, Manolis, Antonis S

    Published in Current vascular pharmacology (01-01-2020)
    “…Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by venous, arterial or microvascular thrombosis or obstetric events in the…”
    Get more information
    Journal Article
  16. 16

    Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases by Manolis, Antonis S, Tzioufas, Athanasios G

    Published in Current vascular pharmacology (01-01-2020)
    “…In Part 1 of this Thematic Issue entitled "Systemic Autoimmune Rheumatic Diseases and Cardiology", a panel of specialists and experts in cardiology,…”
    Get more information
    Journal Article
  17. 17

    Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature by Manolis, Antonis S

    Published in Current cardiology reviews (01-01-2017)
    “…Background: Transseptal puncture (TSP) remains a demanding procedural step in accessing the left atrium with inherent risks and safety concerns, mostly related…”
    Get full text
    Journal Article
  18. 18

    Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target? by Manolis, Antonis S, Tzioufas, Athanasios G

    Published in Current vascular pharmacology (01-01-2020)
    “…In the current Thematic Issue of Current Vascular Pharmacology (CVP), entitled "Systemic Autoimmune Rheumatic Diseases and Cardiology", presented in two parts,…”
    Get more information
    Journal Article
  19. 19

    Cannabis Associated "High" Cardiovascular Morbidity and Mortality: Marijuana Smoke Like Tobacco Smoke? A Déjà Vu/Déjà Vécu Story? by Manolis, Theodora A, Manolis, Antonis A, Manolis, Antonis S

    Published in Mini reviews in medicinal chemistry (01-01-2019)
    “…Cannabis use has increased over the past several years as some countries have legalized its use for the treatment of certain medical conditions and/or for…”
    Get more information
    Journal Article
  20. 20

    COVID-19 infection and body weight: A deleterious liaison in a J-curve relationship by Manolis, Antonis S., Manolis, Antonis A., Manolis, Theodora A., Apostolaki, Naomi E., Melita, Helen

    Published in Obesity research & clinical practice (01-11-2021)
    “…•Overweight and obesity increase risk in COVID-19 patients by reducing cardiorespiratory reserve and enhancing immune dysregulation.•Visceral obesity promotes…”
    Get full text
    Journal Article